Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?

Jee Hyun Kong, Elliott F. Winton, Leonard T. Heffner, Zhengjia Chen, Amelia A. Langston, Brittany Hill, Martha Arellano, Fuad El-Rassi, Audrey Kim, Anand Jillella, Vamsi Kota, Imre Bodó, Hanna Jean Khoury

Research output: Contribution to journalArticle

7 Scopus citations

Fingerprint Dive into the research topics of 'Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?'. Together they form a unique fingerprint.

Medicine & Life Sciences